Business
Immutep granted European patent for IMP321 in cancer
Immutep granted European patent for IMP321 in cancer
About this update from Immutep Ltd
[{"type":"text","content":"Immutep Ltd has released a press release. View Attachment","length":219,"tagName":"div"}]